Cabergoline in Treatment of Methamphetamine-Dependent Patients and Its Effect on Serum Level of Glial Cell-Derived Neurotrophic Factor: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Mohammadesmaeil Alipour,Maryam Jafarian, Reza Rastgoo,Azarakhsh Mokri,Ali Gorji,Mohammad R Zarrindast, Fahimeh Lorestani,Emran M Razaghi

European addiction research（2021）

引用 1|浏览1

暂无评分

摘要

The findings of this study confirmed the effect of cabergoline in reducing methamphetamine use. However, a serum level of the GDNF increase, as seen in animal studies, was not associated with cabergoline treatment of human subjects. This study was registered at the Iranian Registry of Clinical Trials (TRN:IRCT2015050422077N1, October 06, 2015, https://en.irct.ir/trial/19134).

查看译文

关键词

Cabergoline,Glial cell line-derived neurotrophic factor,Methamphetamine,Substance use disorder

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要